Mostrar el registro sencillo del ítem
dc.contributor.author | Wilks, Samuel H. | |
dc.contributor.author | Mühlemann, Barbara | |
dc.contributor.author | Shen, Xiaoying | |
dc.contributor.author | Türeli, Sina | |
dc.contributor.author | LeGresley, Eric B. | |
dc.contributor.author | Netzl, Antonia | |
dc.contributor.author | Caniza, Miguela A. | |
dc.contributor.author | Chacaltana-Huarcaya, Jesus N. | |
dc.contributor.author | Corman, Victor M. | |
dc.contributor.author | Daniell, Xiaoju | |
dc.contributor.author | Datto, Michael B. | |
dc.contributor.author | Dawood, Fatimah S. | |
dc.contributor.author | Denny, Thomas N. | |
dc.contributor.author | Drosten, Christian | |
dc.contributor.author | Fouchier, Ron A. M. | |
dc.contributor.author | Garcia Funegra, Patricia Jannet | |
dc.contributor.author | Halfmann, Peter J. | |
dc.contributor.author | Jassem, Agatha | |
dc.contributor.author | Jeworowski, Lara M. | |
dc.contributor.author | Jones, Terry C. | |
dc.contributor.author | Kawaoka, Yoshihiro | |
dc.contributor.author | Krammer, Florian | |
dc.contributor.author | McDanal, Charlene | |
dc.contributor.author | Pajon, Rolando | |
dc.contributor.author | Simon, Viviana | |
dc.contributor.author | Stockwell, Melissa S. | |
dc.contributor.author | Tang, Haili | |
dc.contributor.author | van Bakel, Harm | |
dc.contributor.author | Veguilla, Vic | |
dc.contributor.author | Webby, Richard | |
dc.contributor.author | Montefiori, David C. | |
dc.contributor.author | Smith, Derek J. | |
dc.date.accessioned | 2023-12-05T17:48:01Z | |
dc.date.available | 2023-12-05T17:48:01Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/14643 | |
dc.description.abstract | During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)–1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection. | en_US |
dc.language.iso | eng | |
dc.publisher | American Association for the Advancement of Science | |
dc.relation.ispartofseries | Science | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Antigenic | en_US |
dc.subject | Serological | en_US |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Modulación Antigénica | |
dc.subject.mesh | Prueba Serológica para COVID-19 | |
dc.title | Mapping SARS-CoV-2 antigenic relationships and serological responses | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1126/science.adj0070 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.01 | |
dc.relation.issn | 1095-9203 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |